Repetitive transcranial magnetic stimulation may be superior to drug therapy in the treatment of Alzheimer's disease: A systematic review and Bayesian network meta-analysis.

Naili WeiHaoxin LiuWenrui YeShengliang XuChanghao LuAnxiang DaiTing HouXin ZengJie Wu Jian Chen

Published in: CNS neuroscience & therapeutics (2023)

Compared with the current clinical drug treatment, rTMS demonstrated better cognitive function improvement and fewer adverse events in AD patients. Therefore, rTMS shows broad prospects in the treatment of Alzheimer's disease, and it is worth being widely popularized in clinic.

Keyphrases

transcranial magnetic stimulation
high frequency
systematic review
emergency department
ejection fraction
randomized controlled trial
primary care
bone marrow
newly diagnosed
drug induced
replacement therapy